Quality assessment strategy development and analytical method selection of GMP grade biological drugs for gene and cell therapy
Biological drugs with gene and cell therapy potentials, including natural or rationally created biomacromolecules, recombinant proteins/enzymes, gene-carrying DNA/RNA fragments, oncolytic viruses, plasmid and viral vectors or other gene delivering vehicles with specific therapeutic genes and gene ma...
Saved in:
| Main Authors: | Quan-en Yang, Nicole Lee, Nicole Johnson, Jennifer Hong, Jenny (Qinghua) Zhao, Xiulian Sun, Jian Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | BBA Advances |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667160325000146 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of rheumatologists’ knowledge of biosimilars
by: Thayane Furtado Rolim Lima, et al.
Published: (2025-07-01) -
Determination of the Potency of Drugs used in Treatment of Type2 Diabete (A Case Study of Taraba State Specialist Hospital Jalingo)
by: Charity Ebelechukwu Okorie, et al.
Published: (2023-02-01) -
Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region
by: Zoltán Kaló, et al.
Published: (2017-01-01) -
Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation
by: A. V. Nikitina, et al.
Published: (2020-02-01) -
MOLECULAR BIOLOGY AND DRUG THERAPIES OF CHRONIC MYELOID LEUKEMIA: A REVIEW OF RECENT LITERATURE
by: Sameen Shahid, et al.
Published: (2024-03-01)